Identification and clinical relevance of naturally occurring human CD8+HLA-DR+ regulatory T cells

Journal of Immunology

Volumn 193, Issue 9, 2014, Pages 4469-4476

  Arruvito, Lourdes ^a   Payaslián, Florencia ^a   Baz, Plácida ^a   Podhorzer, Ariel ^a   Billordo, Ariel ^a   Pandolfi, Julieta ^a   Semeniuk, Guillermo ^b   Arribalzaga, Eduardo ^a   Fainboim, Leonardo ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; INTERLEUKIN 2;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFANT; MALE; NEWBORN; NON SMALL CELL LUNG CANCER; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; CELL COMMUNICATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; FETUS BLOOD; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL PROLIFERATION; CTLA-4 ANTIGEN; FEMALE; FETAL BLOOD; HLA-DR ANTIGENS; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; INFANT, NEWBORN; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84908125810     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401490     Document Type: Article

References (38)

1. Gershon, R. K., and K. Kondo. 1970. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18: 723-737.
2. Baecher-Allan, C., J. A. Brown, G. J. Freeman, and D. A. Hafler. 2001. CD4+ CD25high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
3. Levings, M. K., R. Sangregorio, and M. G. Roncarolo. 2001. Human CD25(+) CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193: 1295-1302.
4. Ng, W. F., P. J. Duggan, F. Ponchel, G. Matarese, G. Lombardi, A. D. Edwards, J. D. Isaacs, and R. I. Lechler. 2001. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 98: 2736-2744.
5. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336.
6. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
7. Roncador, G., P. J. Brown, L. Maestre, S. Hue, J. L. Martínez-Torrecuadrada, K. L. Ling, S. Pratap, C. Toms, B. C. Fox, V. Cerundolo, et al. 2005. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol. 35: 1681-1691.
8. Jonuleit, H., E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A. H. Enk. 2001. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193: 1285-1294.
9. Fainboim, L., C. Navarrete, and H. Festenstein. 1980. Precursor and effector phenotypes of activated human T lymphocytes. Nature 288: 391-393.
10. Baecher-Allan, C., E. Wolf, and D. A. Hafler. 2006. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176: 4622-4631.
11. Shimizu, K., M. Nakata, Y. Hirami, T. Yukawa, A. Maeda, and K. Tanemoto. 2010. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J. Thorac. Oncol. 5: 585-590.
12. Petersen, R. P., M. J. Campa, J. Sperlazza, D. Conlon, M. B. Joshi, D. H. Harpole, Jr., and E. F. Patz, Jr. 2006. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107: 2866-2872.
13. Nishikawa, H., and S. Sakaguchi. 2010. Regulatory T cells in tumor immunity. Int. J. Cancer 127: 759-767.
14. Appay, V., R. A. van Lier, F. Sallusto, and M. Roederer. 2008. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73: 975-983.
15. Read, S., V. Malmström, and F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
16. Oderup, C., L. Cederbom, A. Makowska, C. M. Cilio, and F. Ivars. 2006. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. Immunology 118: 240-249.
17. Zou, W. 2006. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6: 295-307.
18. Filaci, G., D. Fenoglio, M. Fravega, G. Ansaldo, G. Borgonovo, P. Traverso, B. Villaggio, A. Ferrera, A. Kunkl, M. Rizzi, et al. 2007. CD8+ CD28-T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J. Immunol. 179: 4323-4334.
19. Andersen, M. H., R. B. Sørensen, M. K. Brimnes, I. M. Svane, J. C. Becker, and P. thor Straten. 2009. Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients. J. Clin. Invest. 119: 2245-2256.
20. Jarnicki, A. G., J. Lysaght, S. Todryk, and K. H. Mills. 2006. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J. Immunol. 177: 896-904.
21. Kiniwa, Y., Y. Miyahara, H. Y. Wang, W. Peng, G. Peng, T. M. Wheeler, T. C. Thompson, L. J. Old, and R. F. Wang. 2007. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin. Cancer Res. 13: 6947-6958.
22. Parodi, A., F. Battaglia, F. Kalli, F. Ferrera, G. Conteduca, S. Tardito, S. Stringara, F. Ivaldi, S. Negrini, G. Borgonovo, et al. 2013. CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes. Cancer Immunol. Immunother. 62: 851-862.
23. Wei, S., I. Kryczek, L. Zou, B. Daniel, P. Cheng, P. Mottram, T. Curiel, A. Lange, and W. Zou. 2005. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res. 65: 5020-5026.
24. Tao, H., Y. Mimura, K. Aoe, S. Kobayashi, H. Yamamoto, E. Matsuda, K. Okabe, T. Matsumoto, K. Sugi, and H. Ueoka. 2012. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung Cancer 75: 95-101.
25. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212.
26. Dejean, A. S., D. R. Beisner, I. L. Ch'en, Y. M. Kerdiles, A. Babour, K. C. Arden, D. H. Castrillon, R. A. DePinho, and S. M. Hedrick. 2009. Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat. Immunol. 10: 504-513.
27. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
28. Ise, W., M. Kohyama, K. M. Nutsch, H. M. Lee, A. Suri, E. R. Unanue, T. L. Murphy, and K. M. Murphy. 2010. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nat. Immunol. 11: 129-135.
29. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
30. Kingsley, C. I., M. Karim, A. R. Bushell, and K. J. Wood. 2002. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168: 1080-1086.
31. Cosmi, L., F. Liotta, E. Lazzeri, M. Francalanci, R. Angeli, B. Mazzinghi V. Santarlasci, R. Manetti, V. Vanini, P. Romagnani, et al. 2003. Human CD8+ CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102: 4107-4114.
32. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
33. Lahl, K., C. T. Mayer, T. Bopp, J. Huehn, C. Loddenkemper, G. Eberl, G. Wirnsberger, K. Dornmair, R. Geffers, E. Schmitt, et al. 2009. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. J. Immunol. 183: 5662-5672.
34. Siegmund, K., B. Rückert, N. Ouaked, S. Bürgler, A. Speiser, C. A. Akdis, and C. B. Schmidt-Weber. 2009. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells. J. Immunol. 182: 2124-2130.
35. Ablamunits, V., B. C. Bisikirska, and K. C. Herold. 2008. Human regulatory CD8 T cells. Ann. N. Y. Acad. Sci. 1150: 234-238.
36. Bisikirska, B., J. Colgan, J. Luban, J. A. Bluestone, and K. C. Herold. 2005. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J. Clin. Invest. 115: 2904-2913.
37. Picarda, E., S. Bézie, V. Venturi, K. Echasserieau, E. Mérieau, A. Delhumeau, K. Renaudin, S. Brouard, K. Bernardeau, I. Anegon, and C. Guillonneau. 2014. MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection. J. Clin. Invest. 124: 2497-2512.
38. Rifa'i, M., Y. Kawamoto, I. Nakashima, and H. Suzuki. 2004. Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J. Exp. Med. 200: 1123-1134.